Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity
and mortality. There have been many advances in the field of PE in the last few years …

Pulmonary embolism (PE) represents the third leading cause of cardiovascular mortality.
The technological landscape for management of acute intermediate-and high-risk PE is …

Background Thrombolytic therapy is usually reserved for patients with clinically serious or
massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may …

Background Transthoracic echocardiography (TTE) is often considered for risk stratification
of patients with acute pulmonary embolism (PE). We sought to determine the contemporary …

The prognosis of multidetector computed tomography (MDCT) assessed right ventricular
dilatation (RVD) is unclear in patients with pulmonary embolism (PE) and a simplified …

Abstract Clot-in-transit (CIT) is defined as a mobile echogenic material in the right atrium or
ventricle as observed on ultrasound. A right heart free-floating thrombus is unusual when …

Background Thrombolytic therapy is usually reserved for people with clinically serious or
massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may …

Discussion Right heart thrombus is an uncommon condition that is found in about 4% of
patients with pulmonary emboli. 1, 2 It is often found in transit, originating from a systemic …

OBJECTIVES The presence of right heart thrombi in transit (RHTiT) in the setting of acute
pulmonary embolism (PE) is associated with high mortality. The optimal management in …

Purpose of review Acute pulmonary embolism (PE) is a heterogeneous disease process
whose presentation varies widely between individuals who are asymptomatic, develop …